Caricamento...
Immunotherapy for Non-small-cell Lung Cancer: Current Status and Future Obstacles
Lung cancer is one of the leading causes of death worldwide. There are 2 major subtypes of lung cancer, non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Studies show that NSCLC is the more prevalent type of lung cancer that accounts for approximately 80%–85% of cases. Although,...
Salvato in:
| Pubblicato in: | Immune Netw |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The Korean Association of Immunologists
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5746608/ https://ncbi.nlm.nih.gov/pubmed/29302251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4110/in.2017.17.6.378 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|